scispace - formally typeset
M

Miguel Ángel Jiménez-Arriero

Researcher at Complutense University of Madrid

Publications -  67
Citations -  1961

Miguel Ángel Jiménez-Arriero is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Alcohol dependence & Schizophrenia. The author has an hindex of 24, co-authored 67 publications receiving 1794 citations. Previous affiliations of Miguel Ángel Jiménez-Arriero include Carlos III Health Institute & University of Barcelona.

Papers
More filters
Journal ArticleDOI

The role of behavioral impulsivity in the development of alcohol dependence: A 4-year follow-up study.

TL;DR: The results support the relation between behavioral impulsivity and alcohol use disorders and suggest the paradigm related to delay of reward may be a factor associated with the use of alcohol and the incapacity to control inhibition as dependence develops.
Journal ArticleDOI

Diagnostic stability of psychiatric disorders in clinical practice.

TL;DR: The temporal consistency of mental disorders was poor, ranging from 29% for specific personality disorders to 70% for schizophrenia, with stability greatest for in- patient diagnoses and least for out-patient diagnoses.
Journal ArticleDOI

Long-Acting Injectable Risperidone Compared with Zuclopenthixol in the Treatment of Schizophrenia with Substance Abuse Comorbidity

TL;DR: Long-acting injectable risperidone was more effective than zuclopenthixol-depot in improving substance abuse and schizophrenia symptoms in subjects with dual diagnosis.
Journal ArticleDOI

The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients.

TL;DR: The results support the existence of an association between the A1 allele and factors resulting from dopaminergic deficiency, otherwise denominated reward deficiency syndrome.
Journal ArticleDOI

The ANKK1 kinase gene and psychiatric disorders.

TL;DR: Current data show that the TaqIA polymorphism may be a marker of both DRD2 and ANKK1 genetic variants, which raises the question of whether signaling players intervene in the pathophysiology of psychiatric disorders.